407 related articles for article (PubMed ID: 31585262)
1. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
Pogaku V; Gangarapu K; Basavoju S; Tatapudi KK; Katragadda SB
Bioorg Chem; 2019 Dec; 93():103307. PubMed ID: 31585262
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies.
Peytam F; Adib M; Shourgeshty R; Mohammadi-Khanaposhtani M; Jahani M; Imanparast S; Faramarzi MA; Mahdavi M; Moghadamnia AA; Rastegar H; Larijani B
Mol Divers; 2020 Feb; 24(1):69-80. PubMed ID: 30825061
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study.
Azimi F; Ghasemi JB; Azizian H; Najafi M; Faramarzi MA; Saghaei L; Sadeghi-Aliabadi H; Larijani B; Hassanzadeh F; Mahdavi M
Int J Biol Macromol; 2021 Jan; 166():1082-1095. PubMed ID: 33157144
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of thiobarbituric acid derivatives: In vitro α-glucosidase inhibition and molecular docking studies.
Barakat A; Ali M; Mohammed Al-Majid A; Yousuf S; Iqbal Choudhary M; Khalil R; Ul-Haq Z
Bioorg Chem; 2017 Dec; 75():99-105. PubMed ID: 28926784
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B
Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies.
Adib M; Peytam F; Shourgeshty R; Mohammadi-Khanaposhtani M; Jahani M; Imanparast S; Faramarzi MA; Larijani B; Moghadamnia AA; Esfahani EN; Bandarian F; Mahdavi M
Bioorg Med Chem Lett; 2019 Mar; 29(5):713-718. PubMed ID: 30661823
[TBL] [Abstract][Full Text] [Related]
8. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
[TBL] [Abstract][Full Text] [Related]
9. Indole acrylonitriles as potential anti-hyperglycemic agents: Synthesis, α-glucosidase inhibitory activity and molecular docking studies.
Solangi M; Kanwal ; Mohammed Khan K; Saleem F; Hameed S; Iqbal J; Shafique Z; Qureshi U; Ul-Haq Z; Taha M; Perveen S
Bioorg Med Chem; 2020 Nov; 28(21):115605. PubMed ID: 33065441
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion.
Ye GJ; Lan T; Huang ZX; Cheng XN; Cai CY; Ding SM; Xie ML; Wang B
Eur J Med Chem; 2019 Sep; 177():362-373. PubMed ID: 31158750
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Bis-indolylmethane sulfonohydrazides derivatives as potent α-Glucosidase inhibitors.
Gollapalli M; Taha M; Ullah H; Nawaz M; AlMuqarrabun LMR; Rahim F; Qureshi F; Mosaddik A; Ahmat N; Khan KM
Bioorg Chem; 2018 Oct; 80():112-120. PubMed ID: 29894890
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
[TBL] [Abstract][Full Text] [Related]
14. Celebrex derivatives: Synthesis, α-glucosidase inhibition, crystal structures and molecular docking studies.
Kausar N; Ullah S; Khan MA; Zafar H; Atia-Tul-Wahab ; Choudhary MI; Yousuf S
Bioorg Chem; 2021 Jan; 106():104499. PubMed ID: 33288319
[TBL] [Abstract][Full Text] [Related]
15. In search of new α-glucosidase inhibitors: Imidazolylpyrazole derivatives.
Chaudhry F; Naureen S; Huma R; Shaukat A; Al-Rashida M; Asif N; Ashraf M; Munawar MA; Khan MA
Bioorg Chem; 2017 Apr; 71():102-109. PubMed ID: 28160945
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li X; Li J
Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
[TBL] [Abstract][Full Text] [Related]
17. Xanthenone-based hydrazones as potent α-glucosidase inhibitors: Synthesis, solid state self-assembly and in silico studies.
Tariq QU; Malik S; Khan A; Naseer MM; Khan SU; Ashraf A; Ashraf M; Rafiq M; Mahmood K; Tahir MN; Shafiq Z
Bioorg Chem; 2019 Mar; 84():372-383. PubMed ID: 30530108
[TBL] [Abstract][Full Text] [Related]
18. Exploration of aroyl/heteroaroyl iminothiazolines featuring 2,4,5-trichlorophenyl moiety as a new class of potent, selective, and in vitro efficacious glucosidase inhibitors.
Kazmi M; Zaib S; Amjad ST; Khan I; Ibrar A; Saeed A; Iqbal J
Bioorg Chem; 2017 Oct; 74():134-144. PubMed ID: 28780150
[TBL] [Abstract][Full Text] [Related]
19. Oxindole based oxadiazole hybrid analogs: Novel α-glucosidase inhibitors.
Taha M; Imran S; Rahim F; Wadood A; Khan KM
Bioorg Chem; 2018 Feb; 76():273-280. PubMed ID: 29223804
[TBL] [Abstract][Full Text] [Related]
20. 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening.
Thakral S; Singh V
Med Chem; 2019; 15(2):186-195. PubMed ID: 30251608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]